An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

• Status: Completed
• Trial end date: 2011-08-01

Summary

This study investigates the effect of two dose-levels of AP214 on the prevention of (acute) kidney injury after cardiac surgery.

• Phase: Phase 2

Details

• Lead Sponsor: Action Pharma A/S